Worried about your State Pension income? Here are 2 FTSE 100 dividend stocks I’d buy today

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver improving income returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the State Pension amounting to just £8,767 per year, many retirees are likely to need a second income in older age.

Since the FTSE 100 appears to offer good value for money at the present time, with it having a dividend yield of around 4.5%, there are a number of opportunities to generate a growing passive income across the large-cap share universe.

With that in mind, here are two FTSE 100 stocks that could offer an improving income outlook, as well as relatively stable financial performance over the long term.

AstraZeneca

It’s been a difficult journey for pharmaceutical company AstraZeneca (LSE: AZN) over the last decade. It has seen its profitability fall heavily due to the loss of patents on key drugs, with this leading to a lack of dividend growth in recent years.

Now though, the company appears to be in a relatively strong position. It has invested heavily in its pipeline under a strategy that has sought to focus on core growth areas. This strategy is now expected to bear fruit, with the business forecast to post a rise in net profit of around 12% in the current year.

This could stimulate AstraZeneca’s dividend growth prospects, and lead to an improving income outlook for its investors. It now has a dividend yield of just 3.4%, but its potential to increase dividends at a pace that exceeds inflation could lead to a robust outlook from an income perspective.

Alongside this, the company’s defensive appeal could help it to outperform the wider FTSE 100 at a time when the prospects for the global economy remain highly uncertain.

Unilever

Unilever’s (LSE: ULVR) recent updates have shown that its current growth strategy is paying off. It has focused investment on fast-growing markets across the emerging world, with them now making up the lion’s share of its revenue. They are also the main catalyst behind the company’s growth rate, and are likely to remain so over the medium term as wages in countries such as China move higher at a rapid rate.

Like AstraZeneca, Unilever’s dividend yield is below that of the wider FTSE 100 at the present time. The consumer goods company is set to record an income return of just 2.9% in the current year. However, with its bottom line forecast to produce a gain of 10% this year and its dividend payments being covered 1.6 times by profit, the scope for a rapidly-rising dividend seems to be high.

Although Unilever may lack the defensive appeal of some of its FTSE 100 peers, its potential to enjoy above-average growth over the long run seems to be high. It has a wide range of popular brands in a number of different markets. This provides it with a wide economic moat which, alongside its growth potential, makes it an enticing income opportunity for the long term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and Unilever. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

3 of the best FTSE 100 stocks to consider in May

FTSE stocks are back in fashion as investors look for undervalued shares. Here are some our writer Royston Wild thinks…

Read more »

Mixed-race female couple enjoying themselves on a walk
Investing Articles

£7,000 in savings? Here’s what I’d do to turn that into a £1,160 monthly passive income

With some careful consideration, it's possible to make an excellent passive income for life with UK shares. This is how…

Read more »

Investing Articles

If I’d invested £1k in Amazon stock when it went public, here’s what I’d have today

Amazon stock has been one of the biggest winners over the last couple of decades. Muhammad Cheema takes a look…

Read more »

Investing Articles

If I’d put £5,000 in Nvidia stock 5 years ago, here’s what I’d have now

Nvidia stock has been a great success story in the past few years. This Fool breaks down how much he'd…

Read more »

Young black woman walking in Central London for shopping
Investing Articles

Could investing in a Shein IPO make my ISA shine?

With chatter that London might yet see a Shein IPO, our writer shares his view on some possible pros and…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

The FTSE 100 reached record highs in April! Here’s what investors should consider buying in May

The FTSE 100 continues to impress in 2024 as last month it reached new highs. Here are two stocks investors…

Read more »

Investing Articles

Despite hitting a 52-week high, Coca-Cola HBC stock still looks great value

Our writer reckons one flying UK share that has been participating in the recent FTSE 100 bull run remains a…

Read more »

Investing Articles

Is this the best stock to invest in right now?

Roland Head explains why he likes this FTSE 250 business so much and wonders if it could be the best…

Read more »